Gibson, J M
Article History
Received: 23 September 2013
Accepted: 3 October 2013
First Online: 4 July 2014
Competing interests
: The author has received travel re-imbursement and honoraria for attending advisory boards and conferences from Novartis Pharmaceuticals UK Ltd, Bayer PLC, Alimera Sciences, and Allergan Limited. He has received research funding from Novartis Pharmaceuticals UK Ltd and Bayer PLC.